(Q46632215)

23 December 2017

title

Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women (English)

1 reference

23 December 2017

0 references

Andrew Y Y Ho

1

1 reference

23 December 2017

Annie W C Kung

series ordinal

2

1 reference

23 December 2017

language of work or name

English

0 references

publication date

2 August 2005

1 reference

23 December 2017

Annals of Pharmacotherapy

published in

1 reference

23 December 2017

volume

39

1 reference

23 December 2017

issue

9

1 reference

23 December 2017

page(s)

1428-1433

1 reference

23 December 2017

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

cites work

1 reference

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

21 January 2018

1 reference

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis

21 January 2018

1 reference

Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study

21 January 2018

1 reference

Weekly administration of alendronate: rationale and plan for clinical assessment

21 January 2018

1 reference

Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis

21 January 2018

1 reference

Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate

21 January 2018

1 reference

Patients with osteoporosis prefer once weekly to once daily dosing with alendronate

21 January 2018

1 reference

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E580

1 reference

23 December 2017

PubMed ID

16076919

1 reference

23 December 2017